Cite Filings / HQL / 0001062993-25-006767

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

abrdn Life Sciences Investors Filed 2025-04-01 Acc 0001062993-25-006767

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-09-03 SCHEDULE 13D/A Beneficial Ownership Report
2025-04-07 4 10% owner sold 17,210 shares at an average $11.97 ($205,932)
2025-04-03 4 10% owner sold 46,723 shares at an average $12.34 ($576,754)
2025-04-01 4 10% owner sold 48,623 shares at $12.58 ($611,677)
2025-04-01 SCHEDULE 13D/A Beneficial Ownership Report
2025-03-31 4 10% owner sold 36,524 shares at an average $13.00 ($474,961)
2025-03-25 4 10% owner sold 2,329 shares at $13.21 ($30,766)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…